Durvalumab in Endometrial Cancer: DUO-E Trial Updates | OncLive
Durvalumab in Endometrial Cancer: DUO-E Trial Updates | OncLive
Nov 4, 2024
onclive.com
Real-World Use of Durvalumab Tremelimumab in Advanced HCC | OncLive
Real-World Use of Durvalumab Tremelimumab in Advanced HCC …
Oct 28, 2022
onclive.com
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC | OncLive
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metastatic NSCLC: 5-Year Overall Survival Update from the POSEIDON Study | OncLive
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…
Feb 26, 2024
onclive.com
7.7K views · 52 reactions | In patients with muscle-invasive bladder cancer, recurrences after standard treatment are common. Adding perioperative durvalumab to standard treatment may improve outcomes. Research findings are summarized in a new Quick Take video. Full research findings in comments. | The New England Journal of Medicine | Facebook
2:30
7.7K views · 52 reactions | In patients with muscle-invasive blad…
1.7K views1 month ago
FacebookThe New England Journal of Medicine
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
DUO-E Trial: Durvalumab With or Without Olaparib for Endometrial …
Jan 6, 2022
targetedonc.com
2:08
No new advances in systemic treatments for limited-stage small …
1.7K viewsOct 14, 2024
FacebookThe New England Journal of Medicine
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
HIMALAYA Trial: First-Line Tremelimumab Plus Durvalumab I…
Oct 2, 2022
ascopost.com
EMERALD-3: tremelimumab durvalumab with or without lenvat…
Sep 10, 2022
vjoncology.com
Dr. Kato on the Rationale For Investigating Dato-DXd Plus Durv…
Sep 20, 2023
onclive.com
1:29
FDA Approves Perioperative Durvalumab Plus Chemo for Musc…
10 months ago
onclive.com
Dr. Halmos on the FDA Approval of Tremelimumab Plus Durvalumab a…
Nov 11, 2022
onclive.com
Dr Westin on the FDA Approval of Durvalumab Plus Chemo in dMM…
Aug 8, 2024
onclive.com
7:47
Durvalumab and BCG: A New Treatment Option for High-Risk Bl…
1 views2 months ago
YouTubeThe Open Forum
0:51
Marcel D’Allende survived Lung Cancer | carboplatin | pemetrexed …
830 views1 month ago
YouTubeCancer Interviews
Durvalumab plus bevacizumab, added to TACE, shows benefit for …
74 viewsFeb 20, 2024
YouTubeecancer
ascor-gi-2025-insights-real-world-outcomes-of-durvalumab-tremeli…
11 months ago
vumedi.com
Pronunciation of the word(s) "Durvalumab".
4.6K viewsSep 25, 2020
YouTubeSAYTHEWORD-Learn English Pronunciations …
WATCH: Dr Senan Discuss the Significance of the FDA Approval …
224 viewsDec 7, 2024
YouTubeOncLive
Durvalumab following chemoradiotherapy improves surv…
367 viewsJun 26, 2024
YouTubeecancer
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.3K viewsFeb 25, 2020
YouTubeTargeted Oncology
3:49
Preparing for Immunotherapy
NATIONALLY RATED HOSPITAL
About this channel
YouTubeFox Chase Cancer Center
1:32
Tecentriq (atezolizumab) approved to treat Advanced Bladder Cancer
5.4K viewsApr 18, 2017
YouTubemedXclusive Learning
1:27
The Gallbladder and Bile Ducts | Cancer Research UK
376.1K viewsMay 13, 2019
YouTubeCancer Research UK
3:30
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
81.6K viewsAug 6, 2020
YouTubeYou and Lung Cancer
2:47
The Mechanism of Action of Immunotherapy for Cancer Treatm…
22.2K viewsJul 30, 2020
YouTubeScientific Animations
1:06
The Mechanism of Action of Durvalumab in the Treatment of Ur…
1.5K viewsAug 10, 2016
YouTubeTargeted Oncology
See more videos
Static thumbnail place holder